Details

Autor(en) / Beteiligte

• Granér, M
• Pentikäinen, M.O
• Siren, R
• Nyman, K
• Lundbom, J
• Hakkarainen, A
• Lauerma, K
• Lundbom, N
• Nieminen, M.S
• Taskinen, M.-R

Titel

Electrocardiographic changes associated with insulin resistance

Ist Teil von

• Nutrition, metabolism, and cardiovascular diseases, 2014-03, Vol.24 (3), p.315-320

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2014

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Abstract Background and aim Cardiac steatosis has been related to increased risk of heart disease. We investigated the association between cardiac steatosis, electrocardiographic (ECG) abnormalities, and individual components of the metabolic syndrome (MetS). Methods and results A 12-lead ECG and laboratory data were examined in 31 men with the MetS and in 38 men without the MetS. Myocardial triglyceride (MTG) content was measured with 1.5 T magnetic resonance (MR) spectroscopy and epicardial and pericardial fat by MR imaging. MTG content, epicardial and pericardial fat depots were higher in men with the MetS compared with subjects without the MetS ( p  < 0.001). The heart rate was increased ( p  < 0.001), the PR interval was longer ( p  < 0.044), the frontal plane QRS axis shifted to the left ( p  < 0.001), and the QRS voltage ( p  < 0.001) was lower in subjects with the MetS. The frontal plane QRS axis and the QRS voltage were inversely correlated with MTG content, waist circumference (WC), body mass index (BMI), TGs, and fasting blood glucose. High-density lipoprotein cholesterol correlated positively and measures of insulin resistance negatively with the QRS voltage. MTG content and hypertriglyceridemia were determinants of the frontal plane QRS and WC and hyperglycemia were predictors of the QRS voltage. Conclusion The MetS and cardiac steatosis appear to associate with multiple changes on 12-lead ECG. The frontal plane QRS axis is shifted to the left and the QRS voltage is lower in subjects with the MetS. Standard ECG criteria may underestimate the presence of left ventricular hypertrophy in obese subjects with cardiometabolic risk factors.